<DOC>
	<DOCNO>NCT01892137</DOCNO>
	<brief_summary>The main purpose trial demonstrate predictive value clinical diagnosis clearance Actinic Keratoses treatment Ingenol Mebutate use histopathological examination standard .</brief_summary>
	<brief_title>Histological Confirmation Clinical Clearance Actinic Keratoses Following Treatment With Ingenol Mebutate Gel , 0.05 %</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>Must male female least 18 year age . Female patient must nonchildbearing potential childbearing potential negative serum urine pregnancy test use effective contraception Ability provide inform consent Subjects must 59 clinically typical , visible discrete AK lesion within contiguous 25cm2 treatment area trunk extremity except back hand AK confirm histopathology one AK 's prior inclusion location select treatment area within 5cm incompletely heal wound within 10cm suspect basal cell carcinoma squamous cell carcinoma undergone Cosmetic therapeutic procedure use acidcontaining therapeutic product within 2cm selected treatment area 2 week prior Visit 1 use topical creams/lotions , artificial tanner topical steroid within 2cm select treatment area 2 week prior visit 1. treatment immunomodulators , interferon/interferon inducer systemic medication suppress immune system within 4 week visit 1 treatment 5FU , imiquimod , diclofenac , ingenol mebutate photodynamic therapy within 2cm treatment area 8 week prior visit 1 use systemic retinoids currently participate interventional clinical trial female pregnant breastfeed know suspected able comply requirement protocol provide consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Actinic Keratosis</keyword>
	<keyword>Histopathology</keyword>
	<keyword>Reflectance Confocal Microscopy</keyword>
	<keyword>Local Skin Reaction</keyword>
</DOC>